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These data document the vitality of mature mouse oocytes (Meta-
phase II (MII)) and early stage embryos (zygotes) following exposure
to the genotoxic chemotherapeutic agent, etoposide, in combination
with PSC833, a selective inhibitor of permeability glycoprotein. They
also illustrate the vitality of parthenogenetically activated and ferti-
lized embryos following incubation with the calcium chelator BAPTA-
AM (1,2-Bis(2-aminophenoxy)ethane- N,N,N0,N0-tetraacetic acid tet-
rakis (acetoxymethyl ester)), cycloheximide (an antibiotic that is
capable of inhibiting protein synthesis), and hydrogen peroxide (a
potent reactive oxygen species). Finally, they present evidence that
permeability glycoprotein is not represented in the proteome of
mouse spermatozoa. Our interpretation and discussion of these data
feature in the article “Identiﬁcation of a key role for permeability
glycoprotein in enhancing the cellular defense mechanisms of ferti-
lized oocytes” (Martin et al., in press) [1].
& 2016 The Authors. Published by Elsevier Inc. This is an open access
article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).vier Inc. This is an open access article under the CC BY license
/j.ydbio.2016.06.035
u (J.H. Martin).
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xperimental
factorsMouse oocytes and zygotes were treated with etoposide (100 mg/ml) for 15 min
when appropriate. Those used in the examination of permeability glycoprotein
(PGP) efﬂux activity were pretreated with either the PGP inhibitor PSC833 for
15 min (5 mM) or with BAPTA-AM (5 mM)), or cycloheximide (20 mg/ml) for 4 h
during the allotted activation/fertilization period.xperimental
featuresMouse oocytes and spermatozoa were harvested and zygotes or parthenotes
produced via IVF or strontium chloride chemical activation, respectively. Oocytes
were treated with etoposide and PSC833 in combination (a selective inhibitor of
PGP), BAPTA-AM or cycloheximide. The cytotoxicity of these drugs was evaluated
by labeling of the cells with a standard vitality reagent for 15 min at 37 °C.ata source
locationN/Aata accessibility All relevant data are presented within this articleValue of the data
 These data provide valuable insight into the maintenance of mature mouse oocyte and zygote
vitality following genotoxic insult with etoposide (100 mg/ml); a chemotherapeutic agent that
elicits a potent inhibition of topoisomerase II α action.
 Similarly, these data indicate that selective pharmacological inhibition of permeability glycoprotein
(PGP) with PSC833 (5 mM), as well as incubation of oocytes in BAPTA-AM (5 mM) and cycloheximide
(20 mg/ml) for periods of up to 4 h following insemination with spermatozoa or activation with
strontium, does not adversely affect oocyte or embryo vitality.
 This information is of use to the scientiﬁc community as it establishes concentrations of various
pharmacological reagents that can be utilized without compromising oocyte and embryo viability.
 Finally, these data provide evidence that mouse spermatozoa do not harbor PGP within their proteome,
thus discounting the possibility of a paternal contribution to elevated levels of PGP found in the zygote.
1. Data
The ﬁles included in this article comprise vitality proﬁles of mouse MII stage oocytes, chemically
activated and fertilized zygotes following exposure to etoposide (100 mg/ml) in combination with
PSC833 (5 mM) (Fig. 1), cycloheximide (20 mg/ml), BAPTA-AM (5 mM) or hydrogen peroxide (1 mM)
(Fig. 3). This latter treatment was included as a positive control. Immunoblots of mouse sperm lysates
with of anti-PGP antibodies are also included in this article (Fig. 2).2. Experimental design, materials and methods
2.1. Reagents
Reagents were purchased from Sigma Aldrich (St Louis, MO, USA) unless otherwise stated. Anti-
permeability glycoprotein (PGP; ab170904) antibody used for immunoblotting was procured from
Abcam (Cambridge, England, UK).
Fig. 1. Co-incubation with etoposide and valspodar (PSC833), a selective inhibitor of PGP efﬂux activity did not see a loss in
oocyte vitality. The cytotoxicity of etoposide and PSC833 were evaluated using as a standard far red detectable live/dead vitality
reagent. Analysis conﬁrmed that in no instance was there an associated decrease in oocyte vitality following treatment
exposure n¼3.
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Gamete retrieval was achieved via superovulation of juvenile (3–5 week old) C57/BL6/CBA F1
female mice. Once primed, the mice were culled using CO2 asphyxiation and the oocytes recovered
from the cumulus mass following incubation in hyaluronidase (300 mg/ml, 3–5 min) [2]. Spermatozoa
were recovered from the cauda epididymides of mature (Z8 weeks) male C57/BL6/CBA F1 mice by
retrograde perfusion via the vas deferens [3]. Sperm capacitation was achieved by incubation in
modiﬁed Biggers, Whitten and Whittingham (BWW) medium supplemented with 1 mg/ml polyvinyl
alcohol and 1 mg/ml methyl-beta cyclodextrin [2].
2.3. Strontium activation and in vitro fertilization (IVF)
Parthenogenic activation was stimulated by incubation of cumulus free oocytes in calcium free
KSOMmedium supplemented with 10 mM strontium chloride for 4 h. In vitro fertilization was carried
out in human tubal ﬂuid (HTF) medium containing 1 mM reduced glutathione (GSH). Recovered
oocytes were co-incubated with 2105 capacitated spermatozoa for 4 h at 37 °C and successful
fertilization (or activation in the case of parthenotes) was assessed by recording the extrusion of the
second polar body and/or pronucleus formation [4].
2.4. Assessment of factors inﬂuencing permeability glycoprotein (PGP) expression
A number of drugs were used to investigate the factors responsible for the notable increase in PGP
labeling following fertilization and activation [1]. The relative contribution of protein translation was
analyzed by the inclusion of cycloheximide (20 mg/ml), an antibiotic with the ability to block protein
synthesis. Alternatively, the role of activation-associated cytosolic calcium oscillations was assessed in
the presence of the calcium chelator, BAPTA-AM (5 mM).
2.5. Etoposide treatment and cellular vitality
MII oocytes, parthenotes and pronuclear stage zygotes, were exposed to etoposide (100 mg/ml for
15 min at 37 °C), a topoisomerase II α inhibitor capable of eliciting DSB DNA damage. The cytotoxicity
Fig. 2. Permeability glycoprotein is absent from mature capacitated mouse spermatozoa. Immunoblotting techniques con-
ﬁrmed that permeability glycoprotein is absent from mature capacitated mouse spermatozoa; no bands were recorded over
three replicates n¼3.
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this investigation were evaluated by labeling of the cells with a far red detectable live/dead vitality
reagent (Thermo Fisher Scientiﬁc, Waltham, MA, USA).
2.6. Immunoﬂuorescence, SDS PAGE and immunoblotting
Following retrieval and appropriate treatment, oocytes were washed in PBS/PVP and ﬁxed by
incubation in 3.7% (v/v) paraformaldehyde for 1 h at room temperature (RT). Oocytes were later
mounted on Menzel Glӓser microscope slides (Thermo Fisher Scientiﬁc) in Mowiol containing 1,4-
diazabicyclo[2.2.2]octane (DABCO) and ﬂuorescence intensity assessed using an AXIO Imager.A1
ﬂuorescence microscope (Carl Zeiss Micro Imaging GmbH, Jena, Thuringia, Germany). SDS PAGE and
immunoblotting was conducted on solubilized (sodium dodecyl sulfate (SDS)) sperm protein extracts. A
total of 10 mg of protein was resolved on pre-cast gels (4–12% NuPAGE BIS-Tris, Thermo Fisher Scientiﬁc)
and transferred to a nitrocellulose membrane. Membranes were blocked in Tris-buffered saline (TBS)
containing 0.1% Tween (TBST) with 3% BSA for 1 h) [7]. Blocked membranes were then sequentially
incubated in anti-PGP primary antibody (1:500 in 3% BSA/TBST) overnight at 4 °C, HRP-conjugated
Fig. 3. Loss of permeability glycoprotein expression is not an artifact of cell death (a,b). Immunoﬂuorescence using a far red
detectable live/dead vitality reagent indicated that oocyte and embryo vitality was conserved following treatment with
cycloheximide, an antibiotic with the ability to block protein synthesis and the calcium chelator BAPTA (1,2-Bis(2-amino-
phenoxy)ethane-N,N,N0 ,N0-tetraacetic acid tetrakis (acetoxymethyl ester)), in the absence of PGP expression n¼3.
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Astral Scientiﬁc, Sydney, NSW, Australia) and reprobed with an anti-α-tubulin antibody (1:4000 in 1%
BSA/TBST) to ensure equal protein loading.
2.7. Statistical analysis
Image processing was achieved using the public sector program, Image J (National Institute of
Health, Bethesda, MD, USA). Statistical signiﬁcance was determined using JMP software (version
10.0.0, SAS Institute, NC, USA). Each experiment was conducted on a minimum of three biological
replicates and expressed as the mean7s.e.m. Differences with a value of Po0.05 were considered
statistically signiﬁcant.Transparency document. Supplementary material
Transparency data associated with this article can be found in the online version at http://dx.doi.
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